Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs.
Kevin L WinthropArne YndestadDan HenrohnSilvio DaneseSara Marsal-BarrilMaria GalindoJohn C WoolcottHyejin JoKenneth KwokAndrea B ShapiroThomas V JonesAnnette DiehlChinyu SuJulian PanesStanley B CohenPublished in: Rheumatology and therapy (2022)
NCT01262118, NCT01484561, NCT00147498, NCT00413660, NCT00550446, NCT00603512, NCT00687193, NCT01164579, NCT00976599, NCT01059864, NCT01359150, NCT02147587, NCT00960440, NCT00847613, NCT00814307, NCT00856544, NCT00853385, NCT01039688, NCT02281552, NCT02187055, NCT02831855, NCT00413699, NCT00661661, NCT00787202, NCT01465763, NCT01458951, NCT01458574, NCT01470612, NCT01877668, NCT01882439, NCT01976364.
Keyphrases